New Drug Approvals - Pt. XIII - Saxagliptin (Onglyza)

On the 31st July 2009 Saxagliptin (tradename Onglyza) was approved for the treatment of Type II diabetes - Type 2 Diabetes is also known as adult-onset diabetes, and also non-insulin-dependent diabetes melittus (NIDDM). It is the type of diabetes that is often associated with obesity, and so is an increasingly common disease/condition in our well-fed western and also developing world cultures.

Saxagliptin (previously known by the research code BMS-477118) is the third orally-dosed Dipeptidyl peptidase-IV (or DPP-IV) inhibitor to market, and is in the same mechanistic class as other 'gliptins' - Sitagliptin (tradename Januvia) and Vildagliptin (tradename Galvus/Eucreas) which are both launched and also others such as Alogliptin (aka SYR322) and Linagliptin (aka BI-1356, and expected tradename Ondero), which are in late stage clinical trials. The DPP-IV drug class has had quite a complex development and commercial history, as web searches will readily show.

Saxagliptin is a small molecule drug (Molecular Weight of 315.4 g.mol-1 for Saxagliptin itself, and 334.43 g.mol-1 for the Saxagliptin monohydrate dosed ingredient), and has low aqueous solubility. Saxagliptin is well absorbed and has low plasma protein binding (<30%),>ca. 15.8 µmol) once a day. The full prescribing information can be found here.

The Saxagliptin structure is (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile. It contains a number of interesting chemical groups, and a clear underlying similarity to a dipeptide can be seen in the 2-D structure (the enzyme DPP-IV, a proteinase, cleaves the two N-terminal amino acids of its substrate peptides)). Normally DPP-IV is involved in the inactivation of two endogenous peptides, GLP-1 and GIP, by DPP-4, blocking this degradation potentiates the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans located in the pancreas. The first functional group of note is the nitrile (the triple bonded nitrogen-carbon unit) - this is essential to the inhibitory activity and is found in several of the other 'gliptins. This group forms a reversible, covalent bond with the residue Ser 630 of DPP-IV. Secondly, there is the bulky, hydrophobic adamantane (or (tricyclo[3.3.1.13,7]decane) group (this is the 3-D cage like portion of the molecule. Simple substituted adamantanes are sometimes drugs in their own right, for example amantadine, memantine and rimantadine. Within the 'gliptins though, the large bulky adamantyl group blocks an intramolecular cyclisation, which inactivates the inhibitor. These nitrile and adamantyl groups are linked via an amide bond, and an unusual 5,3 fused ring system pyrollidine (which resembles the amino-acid proline, found in the corresponding position of natural substrates).

Saxagliptin canonical SMILES: C1CC2(CC3CC1C(C3)(C2)O)C(C(=O)N4C(CC5C4C5)C#N)N Saxagliptin InChI: InChI=1S/C18H25N3O2/c19-8-13-4-11-5-14(11)21(13)16(22)15(20)17-2-1-12-3-10(6-17)7-18(12,23)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12?,13-,14-,15+,17?,18?/m0/s1 Saxagliptin InChIKey: SBBHGAZNWZOMBJ-TXTOARCRSA-N Saxagliptin CAS registry: 361442-04-8 Saxagliptin ChemDraw: Saxagliptin.cdx

The license holder for Saxagliptin is Bristol Myers Squibb and the product website is www.onglyza.com.

Comments

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains: 2,431,025 compounds (of which 2,409,270 have mol files) 3,106,257 compound records (non-unique compounds) 20,772,701 activities 1,644,390 assays 15,598 targets 89,892 documents Data can be downloaded from the ChEMBL FTP site: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and here for a reminder of SureChEMBL is and what it does. This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for local (behind the

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid

Mapping lists of IDs in ChEMBL

In order to facilitate the mapping of identifiers in ChEMBL, we have developed a new type of search in the ChEMBL Interface. Now, it is possible to enter a list of ChEMBL IDs and see a list of the corresponding entities. Here is an example: 1. Open the ChEMBL Interface , on the main search bar, click on 'Advanced Search': 2. Click on the 'Search by IDs' tab: 3. Select the source entity of the IDs and the destination entity that you want to map to: 4. Enter the identifiers, you can either paste them, or select a file to upload. When you paste IDs, by default it tries to detect the separator. You can also select from a list of separators to force a specific one: Alternatively, you can upload a file, the file can be compressed in GZIP and ZIP formats, this makes the transfer of the file to the ChEMBL servers faster. Examples of the files that can be uploaded to the search by IDs can be found here . 5. Click on the search button: 6. You will be redirected to a search resul

The ChEMBL-og

Search This Blog